Mefenamic Acid is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is Mefenamic Acid.
| Product ID | 51991-839_55759dd3-9539-4437-afb9-617fbc6ec41e |
| NDC | 51991-839 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mefenamic Acid |
| Generic Name | Mefenamic Acid |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-10-13 |
| Marketing End Date | 2020-07-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090359 |
| Labeler Name | Breckenridge Pharmaceutical, Inc. |
| Substance Name | MEFENAMIC ACID |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2014-10-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-10-13 |
| Marketing End Date | 2020-07-31 |
| Marketing Category | ANDA |
| Application Number | ANDA090359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-10-13 |
| Marketing End Date | 2020-07-31 |
| Ingredient | Strength |
|---|---|
| MEFENAMIC ACID | 250 mg/1 |
| SPL SET ID: | 2d973c13-ccea-45b6-8d4e-9ba3177c2c11 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0276-0509 | Mefenamic Acid | Mefenamic Acid |
| 42571-258 | Mefenamic acid | Mefenamic acid |
| 51991-839 | Mefenamic Acid | Mefenamic Acid |
| 62250-677 | Mefenamic Acid | Mefenamic Acid |
| 64380-790 | Mefenamic Acid | Mefenamic Acid |
| 66993-070 | Mefenamic Acid | Mefenamic Acid |
| 68180-185 | Mefenamic Acid | Mefenamic Acid |
| 59630-400 | Ponstel | Mefenamic Acid |